Doctors Hospital Cayman proudly announces it is one of the first healthcare providers in the Caribbean region to offer Donanemab, a revolutionary new treatment for Alzheimer’s disease and dementia.
This milestone places the Doctors Hospital neurology department at the forefront of neurological care, delivering advanced, evidence-based treatment options to patients and families battling these devastating conditions.
Alzheimer’s disease is a progressive neurological disorder that causes brain cells to degenerate and die, leading to memory loss and cognitive decline.
Dementia is an umbrella term for a range of neurological conditions (including Alzheimer’s) that impair memory, thinking, and social abilities severely enough to interfere with daily life.
According to the World Health Organization, more than 55 million people worldwide are living with dementia, with Alzheimer’s accounting for up to 70% of these cases.
The Caribbean, like the rest of the world, faces a growing elderly population and rising incidence rates, making early diagnosis and innovative treatments more important than ever.
Introducing Donanemab
Donanemab, developed by Eli Lilly, is one of the first therapies shown to significantly slow the progression of Alzheimer’s disease by targeting amyloid plaques in the brain which is believed to be a key driver of the disease.
This marks a new era in Alzheimer’s care, shifting the focus from symptomatic treatment to disease modification.
Leading the implementation and oversight of Donanemab treatment at Doctors Hospital is Dr. Ryan Punambolam, expert neurologist and a recognised leader in neurological care across the region.
A proven driver of patient-centred innovation, he is known for introducing best-in-class treatments and protocols that prioritise patient outcomes and long-term wellness.
Already treating patients
“We are not just offering Donanemab – we are already treating patients and closely monitoring their progress to ensure safety and efficacy, and it is part of a comprehensive care pathway including critically important lifestyle and vascular health intervention” said Dr. Punambolam. “Early data and clinical trials are promising, and we’re excited to bring hope and clarity to patients and families affected by Alzheimer’s in the Cayman Islands and across the Caribbean.”
The neurology department at Doctors Hospital has rapidly emerged as a regional centre of excellence in neurological care.
With state-of-the-art imaging, diagnostics, and personalised treatment protocols, patients can now receive world-class care without having to leave the region.
Patients, families and caregivers are invited to consult with the Doctors Hospital team for assessments, second opinions, and eligibility for Donanemab treatment by calling its patient care team on 325-9000 or email [email protected].
Related Videos
